Rep. Maloney Releases Staff Report, Documents Showing Abusive Drug Pricing and Anticompetitive Practices by AbbVie
May 19, 2021
May 19, 2021
WASHINGTON, May 19 (TNSRep) -- Rep. Carolyn Maloney, D-New York, chair of the House Oversight and Reform Committee, issued the following statement on May 18, 2021:
* * *
Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement after releasing a staff report with new documents and details about AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica. AbbVie has repeatedly raised the pri . . .
* * *
Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, issued the following statement after releasing a staff report with new documents and details about AbbVie Inc., which sells the anti-inflammatory drug Humira and the cancer drug Imbruvica. AbbVie has repeatedly raised the pri . . .